Zomig-ZMT

The active ingredient in Zomig-ZMT is zolmitriptan. It is a selective serotonin receptor agonist that will cause blood vessels to constrict. It is also thought to inhibit the pain signals being sent to the brain, thereby reducing acute migraine pain.

Follow all directions given to you by your doctor and read all documents provided, including the full Prescribing Information, FDA-Approved Product Labeling, Instructions for Use, and Medication Guide, before using Zomig-ZMT. However, the following is a synopsis of the general guidelines for the use of Zomig-ZMT:

• Zomig-ZMT is an orally disintegrating tablet that can be taken with or without food. This medication can be taken as needed and does not require a consistent daily dosing schedule.
• Take Zomig-ZMT at the first sign of a headache. If your migraine does not go away, you can take a second dose as long as it has been at least 2 hours since your first dose. You should not take more than 2 doses in a 24-hour period.

The most common side effects of Zomig-ZMT include:

• Shortness of breath or chest pain
• The feeling of heaviness in the body
• Dry mouth
• Drowsiness

Some individuals may experience serious side effects while using Zomig-ZMT. These side effects may require immediate medical attention. If you experience any of the following, contact your healthcare provider or seek emergency medical help:

• Stomach pain that is sudden or severe
• Signs of an allergic reaction, including hives
• Symptoms of a heart attack include trouble breathing, nausea, and angina
• Serotonin syndrome symptoms such as fever, increased heart rate, hallucinations, mood changes, and movement issues

These are not all of the possible side effects of Zomig-ZMT. You should always seek medical advice from your healthcare provider for any questions or concerns about your medical condition or treatment. Read all patient information, medication guides, or drug information sheets that come with this medication. You can also report adverse effects to the Food and Drug Administration at www.fda.gov/medwatch or 1-800-FDA-1088.

Before starting Zomig-ZMT, it is crucial to discuss any existing health conditions with your healthcare provider. You should be sure that your healthcare provider is aware of all your medical conditions, including whether you have:

• High blood pressure (hypertension)
• A family history of coronary artery disease, heart attacks, or you have risk factors such as menopause, diabetes, smoking, obesity, and high cholesterol
• Other heart problems, including irregular heartbeats
• Circulation problems
• Wolff-Parkinson-White syndrome
• Liver disease

• Known allergy to Zomig-ZMT or any inactive ingredients in the product
• Known allergy to any similar medications in the drug class, including sumatriptan (Imitrex), rizatriptan (Maxalt), and almotriptan
• Phenylketonuria (PKU)
• Circulation problems, including conditions such as ischemic bowel disease
• History of heart disease, heart attack, arrhythmia, or stroke
• Currently taking a monoamine oxidase (MAO)-A inhibitor or have taken one within the past 2 weeks
• Have a basilar migraine (a rare type that starts from the base of your brain) or hemiplegic migraine (causes an inability to move on one side).

This medication works quickly, and the patient can experience the medication’s effects within 1 hour.

When Zomig-ZMT is taken with other prescription drugs, over-the-counter medications, vitamins, and supplements, it may change how they work or increase the frequency or severity of side effects. Make sure that you tell your healthcare professional about anything that you are taking to avoid any negative drug interactions, including:

• Cimetidine
• Monoamine oxidase inhibitors (MAOI) within the past 14 days, such as isocarboxazid, tranylcypromine, and phenelzine
• Ergots such as ergotamine, methysergide, and dihydroergotamine

The dosage forms include orally disintegrating tablets, Zomig tablets, and Zomig nasal spray. If a second dose is required for migraine, the patient should wait 2 hours after taking the first dose.

This medication should be stored at room temperature and out of the reach of children.

The pharmaceutical company that manufactures Zomig-ZMT is AstraZeneca.

There are lower-cost alternatives for the brand-name Zomig-ZMT.

Zomig-ZMT can be stopped without tapering according to the product information.

There are no well-controlled studies on the use of Zomig-ZMT in pregnant women. Therefore, it should only be used if the possible benefits outweigh the potential risks to your unborn baby. Talk to your doctor if you are already pregnant or if you have any plans to become pregnant. They will know or recommend what is best for you.

It is not known if this medication can pass through the breastmilk and affect the baby. Talk to your doctor if you are already breastfeeding or if you have any plans to breastfeed. They will know or recommend what is best for you.